Brief: Cerus Corp Announces CMS Has Granted New Technology Add-On Payment For Intercept Fibrinogen Complex
Aug 3 (Reuters) - Cerus Corp CERS.O :
* CERUS CORPORATION ANNOUNCES CMS HAS GRANTED NEW TECHNOLOGY
ADD-ON PAYMENT FOR INTERCEPT FIBRINOGEN COMPLEX
Source text for Eikon: ID:nBw8gk7vha
Further company coverage: CERS.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Cerus
See all newsCerus Corp reports results for the quarter ended June 30 - Earnings Summary
Cerus Q2 adjusted EBITDA misses estimates, raises 2026 outlook
Brief: Cerus Q2 Gross Profit USD 29.5 Million
Cerus Corp expected to post a loss of 1 cent a share - Earnings Preview
Brief: Cerus Corporation Closes New Debt Facility Of Up To $110 Million